摘要
Regenerative medicine has a three-body problem: alignment of the dynamics of the genome, stem cell and patient. Focusing on the rare inherited fragile skin disorder epidermolysis bullosa, three recent innovative studies have used induced pluripotent stem cells and gene correction, revertant mosaicism or genome editing to advance the prospects of better cell-based therapeutics to restore skin structure and function for epidermolysis bullosa and potentially other inherited diseases.
原文 | English |
---|---|
文章編號 | 15 |
期刊 | Genome Medicine |
卷 | 7 |
發行號 | 1 |
DOIs | |
出版狀態 | Published - 2015 2月 20 |
All Science Journal Classification (ASJC) codes
- 分子醫學
- 分子生物學
- 遺傳學
- 遺傳學(臨床)